1. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022, Urologic Cancers CrossRef
2. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
   Eleonora A. Braga et al, 2019, Frontiers in Genetics CrossRef
3. Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
   Anthony Quagliano et al, 2020, Frontiers in Oncology CrossRef
4. Current status and future perspectives in dysregulated miR-492
   Jinze Shen et al, 2023, Gene CrossRef
5. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients
   Zhuoxing Liu et al, 2015, Molecular and Cellular Biochemistry CrossRef
6. Inhibition of microRNA‑492 attenuates cell proliferation and invasion in retinoblastoma via directly targeting LATS2
   Zhiqun Sun et al, 2018, Molecular Medicine Reports CrossRef
7. MicroRNA Signature in Renal Cell Carcinoma
   Soudeh Ghafouri-Fard et al, 2020, Frontiers in Oncology CrossRef
8. Applications of noncoding RNAs in renal cancer patients
   Eman A. Toraih et al, 2022, Clinical Applications of Non-Coding RNAs in Cancer CrossRef
9. Circular RNA circ_0001368 inhibited growth and invasion in renal cell carcinoma by sponging miR-492 and targeting LATS2
   Lin Chen et al, 2020, Gene CrossRef
10. The paradigm of drug resistance in cancer: an epigenetic perspective
    Swagata Adhikari et al, 2022, Bioscience Reports CrossRef
11. The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma
    Ying‐hua He et al, 2018, Journal of Cellular Physiology CrossRef